John Johnson, CEO & President at SAVIENT PHARMACEUTICALS INC (SVNT), bought 11,000 shares at $2.36 ($25K) on 2011-11-18, disclosed to the SEC on 2011-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.28 | 10,000 | $23K | 90.6% |
| 2 | $2.36 | 1,000 | $2K | 9.4% |
| Total | $2.29 avg | 11,000 | $25K | 100% |
| Filing → |
| XERS | SELL | 2025-12-19 | $978K | — | Filing → |
| AXGN | SELL | 2025-12-10 | $2.8M | — | Filing → |
| XERS | SELL | 2025-08-15 | $787K | — | Filing → |